Supply Chain & Manufacturing Summit
Tuesday, November 8, 2022 (1:00 PM - 4:00 PM) (EST)
The Supply Chain & Manufacturing Summit gives you the inside scoop on the most critical aspects of the medtech supply chain that you need to know to effectively manage your operations. This virtual event features insight from industry leaders, including an update on the state of our medtech supply chain, best practices for measuring and tracking sustainability initiatives, and perspectives on how supply chain challenges influence investments. This is a great opportunity to build your knowledge and trusted vendor network. This is a great opportunity to build your knowledge and trusted vendor network.
Thanks to the generosity of our sponsors, there is no cost for this program, but registration is required.
|1:00 - 2:00 PM|
State of the Medical Device Supply Chain
This session will discuss the current state and anticipated future state of supply chain for Massachusetts medical device companies. Topics will include: current burning platforms such as access to labor, issues relating to raw materials, sterilization options and supply chain and cyber security. The session will include a high-level presentation or a report that will be available on the MassMEDIC website, as well as a moderated panel of Massachusetts supply chain leaders.
|2:00 - 3:00 PM|
ESG & Sustainability in Your Supply Chain: Measuring & Reporting Progress and Actively Engaging Stakeholder
During the May 2022 MassMEDIC supply chain event, there was much discussion on the value of sustainability & ESG in the supply chain for all sizes of Medical Device companies and their suppliers. In this follow-up discussion, the panel will focus on addressing some of the specific challenges associated with implementing a successful program, including:
Challenges and ideas for all size companies will be discussed.
|3:00 - 4:00 PM||How Supply Chain Challenges Impact Investments|
Supply chain dynamics, including material shortages and labor issues are impacting the medtech investment ecosystem. Join us for this moderated conversation with representatives from strategics and the venture community as they discuss how their perspectives on business development and investments, including M&A, continues to shift given the challenging state of our current supply chain. The conversation will focus on how changes within the medtech manufacturing ecosystem are broadly impacting business priorities and planning, while at the same time considering strategic moves, including investments and acquisitions.
Lisa Brady is the Vice President, Global Sustainability and Chief Sustainability Officer at Insulet Corporation. In this role, she leads the corporate ESG strategy, developing innovative new business models and ecosystems to sustain positive global impact. She has held Executive roles in Sustainability and Corporate Social Responsibility in Supply Chain at Cisco, Dell EMC and EMC Corporation driving strategies and goals in circular economy, social and environmental responsibility, product stewardship, and risk and resiliency. She also spent several years in IT and internal consulting designing and leading transformations. Lisa started her career journey in the healthcare industry where she held leadership positions at Massachusetts General Hospital, Washington University School of Medicine, and provided consulting services to the World Health Organization.
Alyssa's work covers Scope 3 Carbon accounting and reduction efforts, Labor & Human Rights, Ethics & Transparency, and Responsible Sourcing. Prior to life sciences, Alyssa has over a dozen years of corporate sustainability and product compliance in the electronics, manufacturing, and apparel industries. She holds a Bachelors degree in Mechanical Engineering and a Masters degree in Engineering management from Northeastern University in Boston, Massachusetts.
Senior Director/Head of Business Development
Geoff DaCosta currently leads business development activities for Philips’ Image Guided Therapy business, where he focuses on identifying new portfolio expansions in the coronary, peripheral vascular and electrophysiology domains. Prior to Philips, he served in multiple business development and strategy roles at both Medtronic and Covidien, concentrating on both surgical and vascular technologies. Previous to his time in the MedTech industry, he worked in the Transaction Advisory Services group of Ernst & Young, as well as multiple boutique private equity advisory firms. Geoff holds an MBA from the UCLA Anderson School of Management and a BA in Economics from the University of Pennsylvania.
|John S. Harmon PhD, PE |
John represents clients in industry and academia ranging from venturebacked startups to large corporations and academic institutions in a wide range of technologies related to the mechanical, materials, and chemistry fields. John’s strong technical skills combined with his deep knowledge of patent law and industry allows him to align client business goals with specific IP strategies crafted to meet those goals. Representative technologies that John has dealt with include medical devices, wearable sensors, microfluidics, micro and macroencapsulation systems for biologic compounds and cells, additive manufacturing, optics and imaging systems, sports and consumer products, active suspension systems, autonomous vehicles and systems, robotics, polymer processing methods, metallurgy, battery systems and materials, and renewable energy systems.
Shannon Mills has over 25 years of experience in both the automotive and health sciences industries. He has held roles leading manufacturing operations comprised of machining, trimming, packaging and secondary processes, as well as supplier management. This experiences also includes strategic sourcing, development, and execution improvements.
Vice President, Strategy & Business Development (M&A), Specialty Diagnostics Group
Thermo Fisher Scientific
Managing Director, Health Solutions
Narendra Sharma has more than 26 years of process transformation experience in manufacturing, supply chain, quality management, digitization, IT strategy, acquisition and divesture, risk management, and project/portfolio management. He has helped to achieve business goals, build capabilities, strengthen controls, manage risks and enhance organizational health, while focused on patient safety. He possesses global experience across multiple industries, with extensive client service and employee work in North America, South America, Europe, and Asia.
Lisa F. Wilk PE
As CEO, Lisa sets the vision and direction of the firm to ensure client expectations are exceeded to successfully meet their current needs and future challenges. Lisa has extensive experience and expertise strategically integrating environmental, health and safety (EHS) and Environmental, Social and Governance (ESG) with overall business and organizational objectives.